Marc Simmons

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

Yelena Y. Janjigian, Steven B. Maron, Walid K. Chatila et al. · The Lancet Oncology · 2020 · 347 citations · Full text

First-line Pembrolizumab, Esophageal Cancer, Gastrointestinal Oncology +7

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

Raul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader et al. · Neurology · 2021 · 151 citations · Full text

CT in patients with blunt abdominal trauma: clinical significance of intraperitoneal fluid detected on a scan with otherwise normal findings.

Charles Levine, Uday Patel, Ronald H. Wachsberg et al. · American Journal of Roentgenology · 1995 · 93 citations

Coronary vein diameter and flow direction in patients with portal hypertension: evaluation with duplex sonography and correlation with variceal bleeding.

Ronald H. Wachsberg, Marc Simmons · American Journal of Roentgenology · 1994 · 50 citations

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA).

Yelena Y. Janjigian, Joanne F. Chou, Marc Simmons et al. · Journal of Clinical Oncology · 2019 · 48 citations

Esophageal Cancer, Immunology, Immunoediting +23